Previous close | 136.64 |
Open | 136.74 |
Bid | 136.52 x N/A |
Ask | 136.72 x N/A |
Day's range | 136.74 - 137.32 |
52-week range | 135.00 - 161.10 |
Volume | |
Avg. volume | 453 |
Market cap | N/A |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | 17 July 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
In this article, we will take a look at the 10 best long term low risk stocks to buy. To see more such companies, go directly to 5 Best Long Term Low Risk Stocks to Buy. As the latter part of 2022 unfolded, artificial intelligence stocks emerged as a beacon of hope for the market […]
AbbVie's (ABBV) first-quarter earnings and sales beat estimates. Management hikes the EPS guidance on the back of encouraging Skyrizi product sales.
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Johnson & Johnson (JNJ) have what it takes? Let's find out.